DLGI – 10MG (Dextrose (Liganding) Gastro-Incretin Hormone Peptide) – 10MG per vial

Description

Clinical Test Expectation – DLGI – 10MG (Dextrose (Liganding) Gastro-Incretin Hormone Peptide) – Human Subjects : Appetite Suppression – Triple action appetite suppression
Strength – 10MG per vial

Formulation under patent review : Is a Retatrutide equivalent / alternative

Introduction
DLGI is a ligander of the dextrose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors.

This item targets 3 different hunger regulating incretin hormones:
– GIP (gastric inhibitory peptide or glucose-dependent insulinotropic polypeptide) is an incretin hormone that is released from the stomach after food intake. It stimulates the beta-cells in the pancreas to secrete dextrose (affecting insulin).
– GLP-1 (glucagon-like peptide-1) is also an incretin hormone that stimulates the beta-cells to secrete insulin.
– glucagon is a hormone secreted from the alpha-cells in the pancreas. It stimulates dextrose production in the liver and helps maintain adequate plasma glucose concentrations.

Side Effects (seldom seen)
Abdominal pain, nausea, vomiting, diarrhea, or constipation.

Dosing Details – DLGI – 10MG (Dextrose (Liganding) Gastro-Incretin Hormone Peptide)
You inject 2ml water into the vial of DLGI from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 40 (4 unit) on the syringe once a week, and inject it into the tummy under the skin into the fatty skin layer.  The dose does not increase.

How long will a vial last ?
A vial should last 5 weeks.
Retatrutide
Whatsapp our support team now for help with this item or others ! Click HERE to connect with us !